Sofimac Innovation logo

Sofimac Innovation

Europe, Ile-de-France, France, Paris

Description

Sofimac Innovation, formerly known as iSource Gestion, is a prominent French venture capital firm specializing in early-stage investments. Operating as a key entity within the broader Sofimac Partners group, the firm has established itself as a significant player in the French technology and innovation ecosystem. Its strategic focus lies in identifying and nurturing high-potential startups from their nascent stages, providing crucial capital and strategic guidance to facilitate growth.

The firm's investment thesis is primarily centered on disruptive technologies and innovative business models across several key sectors. Sofimac Innovation actively targets opportunities in Digital, Health, Industry, and Deeptech, reflecting a commitment to areas poised for significant transformation. Geographically, its operations are concentrated within France, with a strong presence in Paris and other dynamic regional tech hubs, underscoring its dedication to fostering domestic innovation.

Sofimac Innovation typically deploys initial capital ranging from €100,000 to €3 million in its portfolio companies. This initial commitment is often followed by subsequent investments, demonstrating the firm's capacity and willingness to support its ventures through multiple funding rounds as they scale. As part of Sofimac Partners, the group collectively manages over €500 million in assets under management, providing a robust financial foundation for its investment activities and enabling substantial follow-on capacity.

With a history rooted in iSource Gestion, Sofimac Innovation leverages extensive experience and a deep network to assist its portfolio companies beyond mere capital injection. The firm emphasizes a collaborative approach, working closely with founders to navigate challenges, accelerate market entry, and achieve sustainable growth. Their long-term commitment to supporting innovative French enterprises solidifies their reputation as a pivotal partner for early-stage tech ventures.

Investor Profile

Sofimac Innovation has backed more than 20 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 20% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series Unknown, Series B rounds (top funding stages).
  • Majority of deals are located in France, The Netherlands, United States.
  • Strong thematic focus on Software, Health Care, Biotechnology.
  • Typical check size: $108K – $3.2M.

Stage Focus

  • Series A (35%)
  • Series Unknown (30%)
  • Series B (15%)
  • Seed (15%)
  • Private Equity (5%)

Country Focus

  • France (90%)
  • The Netherlands (5%)
  • United States (5%)

Industry Focus

  • Software
  • Health Care
  • Biotechnology
  • Medical Device
  • Electronics
  • Information Technology
  • Manufacturing
  • Semiconductor
  • Pharmaceutical
  • Industrial Engineering
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sofimac Innovation frequently co-invest with?

Supernova Invest
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Applied Ventures
North America, California, United States, Santa Clara
Co-Investments: 1
BU
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Sud Rhone-Alpes Capital
Europe, Rhone-Alpes, France, Grenoble
Co-Investments: 2
The Faktory Fund
Europe, Liege, Belgium, Liège
Co-Investments: 2
KREAXI
Europe, Rhone-Alpes, France, Limonest
Co-Investments: 2
Cemag Invest
Europe, Ile-de-France, France, Paris
Co-Investments: 2
BNP Paribas Développement
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 5
Crédit Agricole
Europe, Ile-de-France, France, Montrouge
Co-Investments: 2

What are some of recent deals done by Sofimac Innovation?

Nestwave

Paris, Ile-de-France, France

Nestwave is a provider of advanced geolocation solutions for the IoT market.

Wireless
Series UnknownApr 14, 2021
Amount Raised: $2,876,318
GLIMPS

Cesson-sévigné, Bretagne, France

GLIMPS is a developer of artificial intelligence-powered cyber security software that identifies malware and threats.

Artificial Intelligence (AI)Cyber SecurityNetwork SecuritySoftware
Series AApr 13, 2021
Amount Raised: $7,173,601
AcuSurgical

Montpellier, Languedoc-Roussillon, France

AcuSurgical is a company focused on robotic microsurgery.

Health CareMedical Device
Series AFeb 18, 2021
Amount Raised: $6,952,884
Stirweld

Saint-grégoire, Bretagne, France

Stirweld is a company that develops new friction stir welding (FSW) technologies for machines and tools.

Industrial AutomationIndustrial EngineeringIndustrial Manufacturing
SeedFeb 17, 2021
Amount Raised: $2,409,348
ELWAVE

Delft, Zuid-Holland, The Netherlands

ELWAVE is a manufacturer of electromagnetic detection systems for underwater and industrial robotics.

IndustrialManufacturingRoboticsSemiconductor
SeedJan 20, 2021
Amount Raised: $2,422,941
Antaios

Grenoble, Rhone-Alpes, France

Antaios develops an innovative memory technology.

ManufacturingSemiconductor
Series ADec 16, 2020
Amount Raised: $11,000,000
Vulkam

Saint-martin-d'heres, Rhone-Alpes, France

Vulkam is an innovative microtechnology start up from the french research laboratories.

Industrial Engineering
Series AFeb 4, 2020
Amount Raised: $3,865,733
Beekast

Paris, Ile-de-France, France

Beekast is an online platform (saas) that helps you create, lead and track your meetings, events and training sessions.

CollaborationE-LearningEdTechHuman ResourcesInformation TechnologyInternetMarket ResearchSoftwareTrainingVideo Conferencing
Series AJan 1, 2020
Amount Raised: $5,609,481
Diabeloop

Grenoble, Rhone-Alpes, France

Diabeloop is a medical device company for diabetes and closed-loop system.

Clinical TrialsHealth CareMedicalMedical Device
Series BDec 2, 2019
Amount Raised: $34,337,388
Zionexa

Fishers, Indiana, United States

Zionexa is an international and innovative company developing and commercializing in-vivo biomarkers.

Biotechnology
Private EquityApr 11, 2019
Amount Raised: $5,000,000